http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3977222-B2

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-20
filingDate 2002-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-3977222-B2
titleOfInvention 3,4-Dihydro-1H-naphthalene derivative having excellent selectivity as a cyclooxygenase-2 inhibitor
abstract The present invention relates to a novel 3,4-dihydro-lH-naphthalene derivative having a structure of formula 1 or formula 2, its pharmaceutically acceptable salts and their geometric isomers as a highly selective cyclooxygenase-2 inhibitor. <CHEM> <CHEM> Wherein, R<1>, R<2>, X, A and Q are defined in this specification respectively.
priorityDate 2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246227
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009407
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469616
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282023
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464713
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19225
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24693
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009248
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5742
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443551
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466853624
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443460

Total number of triples: 54.